Effects of renal sympathetic denervation on the atrial electrophysiology in dogs with pacing-induced heart failure

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 10, 2014, Pages 1357-1366

  Wang, Xiaozhan ^a   Zhao, Qingyan ^a   Deng, Hongping ^a   Wang, Xule ^a   Guo, Zongwen ^a   Dai, Zixuan ^a   Xiao, Jinping ^a   Wan, Peixing ^a   Huang, Congxin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

atrial fibrillation; electrophysiology; heart failure; renal sympathetic denervation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEAGLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART RIGHT VENTRICLE; HEART STIMULATION; HEART VENTRICLE PACING; KIDNEY DENERVATION; MALE; NONHUMAN; P WAVE; PACEMAKER IMPLANTATION; RENAL SYMPATHETIC DENERVATION; ANIMAL; ATRIAL FIBRILLATION; DOG; ELECTROPHYSIOLOGY; HEART ATRIUM; HEART ATRIUM REMODELING; HEART FUNCTION TEST; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; SYMPATHECTOMY;

ANIMALS; ATRIAL FIBRILLATION; ATRIAL REMODELING; DOGS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; HEART ATRIA; HEART FAILURE; KIDNEY; MALE; SYMPATHECTOMY;

EID: 84908030802     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12429     Document Type: Article

References (29)

1. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925.
2. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW,. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J Am Coll Cardiol 1998; 32: 695-703.
3. Fonarow G,. Overview of acutely decompensated congestive heart failure (ADHF): A report from the ADHERE registry. Heart Fail Rev 2004; 9: 179-185.
4. De Ferrari GM, Klersy C, Ferrero P, Fantoni C, Salerno-Uriarte D, Manca L, Devecchi P, et al. ALPHA Study Group: Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail 2007; 9: 502-509.
5. Kannel WB, Abbott RD, Savage DD, McNamara PM,. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018-1022.
6. Burstein B, Nattel S,. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
7. Nickenig G, Harrison DG,. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part I: Oxidative stress and atherogenesis. Circulation 2002; 105: 393-396.
8. Dohi Y, Ohashi M, Sugiyama M, Takase H, Sato K, Ueda R,. Candesartan reduces oxidative stress and inflammation in patients with essential hypertension. Hypertens Res 2003; 26: 691-697.
9. DiBona GF, Sawin LL,. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 1991; 260: R298-R305.
10. Zhao QY, Yu SB, Huang H, Tang YH, Xiao JP, Dai ZX, Wang XL, et al. Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure. Int J Cardiol 2013; 168: 1672-1673.
11. Zhao QY, Huang H, Zhang SD, Tang YH, Wang X, Zhang YG, Salim M, et al. The relation between atrial remodeling and inducibility of atrial fibrillation after epicardial ganglionic plexi ablation. Europace 2010; 12: 805-810.
12. Nattel S, Burstein B, Dobrev D,. Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circ Arrhythm Electrophysiol 2008; 1: 62-73.
13. Burstein B, Nattel S,. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
14. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001; 38: 883-891.
15. Nao T, Ohkusa T, Hisamatsu Y, Inoue N, Matsumoto T, Yamada J, Shimizu A, et al. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol 2003; 91: 678-683.
16. Li D, Fareh S, Leung TK, Nattel S,. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999; 100: 87-95.
17. Burstein B, Comtois P, Michael G, Nishida K, Villeneuve L, Yeh YH, Nattel S,. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Circ Res 2009; 105: 1213-1222.
18. Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi WS, Patterson E, Po S, Lazzara R,. Electrical stimulation to identify neural elements on the heart: Their role in atrial fibrillation. J Interv Card Electrophysiol 2005; 13: 37-42.
19. Scherlag BJ, Yamanashi W, Patel U, Lazzara R, Jackman WM,. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol 2005; 45: 1878-1886.
20. Zhou J, Scherlag BJ, Edwards J, Jackman WM, Lazzara R, Po SS,. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi. J Cardiovasc Electrophysiol 2007; 18: 83-90.
21. Hou Y, Scherlag BJ, Lin J, Zhang Y, Lu Z, Truong K, Patterson E, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: Effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol 2007; 50: 61-68.
22. Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM, Zhao L, Ghias M, et al. Atrial fibrillation begets atrial fibrillation: Autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol 2008; 1: 184-192.
23. Lu Z, Scherlag BJ, Lin J, Yu L, Guo JH, Niu G, Jackman WM, et al. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: Evidence by ablation of ganglionated plexi. Cardiovasc Res 2009; 84: 245-252.
24. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD,. Renal sympathetic nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361: 932-934.
25. Zucker IH, Gorman AJ, Cornish KG, Lang M,. Impaired atrial receptor modulation or renal nerve activity in dogs with chronic volume overload. Cardiovasc Res 1985; 19: 411-418.
26. Wang W, Zucker IH,. Cardiac sympathetic afferent reflex in dogs with congestive heart failure. Am J Physiol 1996; 271: R751-R756.
27. Wang W, Ma R,. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev 2000; 5: 57-71.
28. Olsson L, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, et al. CHARM Investigators: Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006; 47: 1997-2004.
29. Natale A, Raviele A, Arentz T, Calkins H, Chen SA, Haïssaguerre M, Hindricks G, et al. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007; 18: 560-580.